Establishment Labs gains on US FDA approval for more Motiva implant sizes

Establishment Labs Holdings

05/10/2026 14:19

** Shares of Establishment Labs ESTA.O rise 1.5% to $65 premarket
** ESTA says FDA approves 28 additional sizes of co's Motiva breast implants for US market
** New sizes include implants as small as 105 cc and will be commercially available before year-end
     ** BTIG says expanded range could open up about 10% of augmentation market that co was not previously serving
** Brokerage sees approval as an important catalyst that could boost surgeon adoption and US market share over time
** As of last close, stock down 12.1% YTD

 (Reporting by Siddhi Mahatole in Bengaluru)
 ((siddhi.mahatole@thomsonreuters.com))